BeStock  
Stocks › Biotechnology › MLYS

Mineralys Therapeutics MLYS

US equityMarket cap rank #2754Biotechnology
$23.30 −$0.33 (-1.40%)
Pre-market · Oct 6, 4:10 am ET · After hours $23.40 +0.43%
Open$23.98
Prev close$23.63
Day range$22.97 – $24.00
Volume1.08M
Market cap$2.06B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$51.00+118.9% vs. price
  • Buy 100%
Low $40.00Now $23.30Avg $51.00High $56.00

Recent rating changes

The last 20 actions on file set price targets from $40.00 to $56.00, averaging $50.71.

DateFirmRatingTarget
12 Aug 2026 Wells Fargo BUY $55.00
12 Aug 2026 LifeSci Capital BUY $54.00
12 Aug 2026 BofA Securities BUY $49.00
12 Aug 2026 Goldman Sachs BUY $40.00
12 Aug 2026 Guggenheim BUY $52.00
12 Aug 2026 H.C. Wainwright BUY $56.00
3 Jun 2026 Goldman Sachs BUY $42.00
1 Jun 2026 LifeSci Capital BUY $54.00
1 Jun 2026 H.C. Wainwright BUY $56.00
18 May 2026 Goldman Sachs BUY $42.00
18 May 2026 Guggenheim BUY $48.00
9 May 2026 LifeSci Capital BUY $54.00
7 May 2026 LifeSci Capital BUY $54.00
7 May 2026 BofA Securities BUY –
7 May 2026 Stifel BUY $52.00
7 May 2026 Goldman Sachs BUY $42.00
7 May 2026 H.C. Wainwright BUY $56.00
6 May 2026 TD Cowen BUY –
27 Apr 2026 TD Cowen BUY –
16 Mar 2026 H.C. Wainwright BUY $56.00

Discussion

No comments yet — be the first to weigh in on MLYS.

Leave a comment

Scroll to Top